Please wait while we load the requested 10-K report or click the link below:
|HOLX||Q4 2012 Earnings Call||Nov. 12, 2012|
|Ticker p||Event Type p||Date p|
Deborah R. Gordon Vice President-Investor Relations
Robert A. Cascella President, Chief Executive Officer & Director
Glenn P. Muir CFO, Director & Executive VP-Administration
Carl W. Hull Senior Vice President & GM-Diagnostics Segment
Peter K. Soltani Senior Vice President & GM-Breast Health
Vijay M. Kumar Analyst, International Strategy & Investment Group, Inc.
Isaac Ro Analyst, Goldman Sachs & Co.
Richard Newitter Analyst, Leerink Swann LLC
Doug Schenkel Analyst, Cowen & Co. LLC
David R. Lewis Analyst, Morgan Stanley & Co. LLC
Amit Bhalla Analyst, Citigroup Global Markets (United States)
Tycho W. Peterson Analyst, JPMorgan Securities LLC
Anthony C. Petrone Analyst, Jefferies & Co., Inc.
Bill R. Quirk Analyst, Piper Jaffray, Inc.
Barbara Lennox Ketner Analyst, Bank of America
Jason R. Mills Analyst, Canaccord Genuity, Inc.
MANAGEMENT DISCUSSION SECTION
Operator: Good afternoon, ladies and gentlemen and welcome to the Hologic Incorporated Fourth Quarter and Fiscal Year 2012 Earnings Conference Call. My name is Kelsey and I am your operator for todays conference. Todays conference call is being recorded and all lines have been placed on mute. I will now turn the conference over to Deborah Gordon, Vice President, Investor Relations. Please go ahead, Ms. Gordon.
Deborah R. Gordon, Vice President-Investor Relations
Thank you, Kelsey. Good afternoon and thank you for joining us for Hologics fourth quarter and fiscal 2012 earnings call. The replay of this call will be archived on our website through Friday, November 30, and a copy of our press release discussing our fourth quarter and fiscal year results as well as our first quarter and fiscal 2013 guidance is available on the Overview section of the Investor Relations page of Hologics website. Also in that section is the PowerPoint presentation related to the comments that will be made during todays opening remarks.
Before we begin, I would like to inform you that certain statements made by Hologic during the course of this call may constitute forward-looking statements. These statements involve known and unknown risks and uncertainties that may cause the actual results to be materially different from any future results implied by such statements. Such factors include those referenced in our Safe Harbor statement and our fourth quarter fiscal 2012 earnings release and in the companys filings with Securities and Exchange Commission.
Also during this call, we will be discussing certain financial measures not prepared in accordance with generally accepted accounting principles or GAAP. A reconciliation of these non-GAAP financial measures to the related GAAP financial measures can also be found in our fourth quarter earnings release, including the financial tables in the release.
www.CallStreet.com 1-877-FACTSET Copyright © 2001-2012 CallStreet 1
The following information was filed by Hologic Inc (HOLX) on Friday, November 16, 2012 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.
View differences made from one year to another to evaluate Hologic Inc's financial trajectory
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were
removed , and by Hologic Inc.